Abstract:Alzheimer’s disease (AD) is a chronic neurodegenerative disease that causes cognitive impairment. Neuroinflammation induced by activated microglia exacerbates AD. Regulatory T cells (Tregs) play roles in limiting neuroinflammation by converting microglial polarization. Therefore, adoptive Treg therapy is considered an attractive option for neurodegenerative disorders. However, the mechanism underlying Treg therapy via microglial modulation is not fully understood. In this study, we sought to determine whether adoptively transferred Tregs were effective when microglia proliferation was inhibited by using GW2580, which is an inhibitor of CSF1R. We found that inhibition of microglial proliferation during Treg transfer did not alter the therapeutic effects of Tregs on cognitive deficits and the accumulation of Aβ and pTAU in 3xTg-AD mice. The expression of pro- and anti-inflammatory markers in the hippocampus of 3xTg mice showed that GW2580 did not affect the inhibition of neuroinflammation by Treg transfer. Additionally, adoptively transferred Tregs were commonly detected in the brain on day 7 after transfer and their levels decreased slowly over 100 days. Our findings suggest that adoptively transferred Tregs can survive longer than 100 days in the brain, suppressing microglial activation and thus alleviating AD pathology. The present study provides valuable evidence to support the prolonged efficacy of adoptive Treg therapy in AD.

What problem does this paper attempt to address?

This paper aims to explore whether regulatory T cells (Tregs) treatment can still have a neuroprotective effect on 3xTg Alzheimer's disease (AD) mice when microglial cell proliferation is inhibited. Specifically, the researchers used the CSF - 1R inhibitor GW2580 to inhibit the proliferation of microglial cells and observed whether this inhibition would affect the therapeutic effects of Tregs on cognitive dysfunction, Aβ accumulation and phosphorylated tau protein (pTAU) accumulation. In addition, the study also evaluated the survival time of Tregs in the brain and its impact on microglial cell polarization. ### Main problems 1. **Efficacy of Tregs under the condition of inhibiting microglial cell proliferation**: The study aims to determine whether Tregs can still effectively improve cognitive dysfunction in 3xTg - AD mice when microglial cell proliferation is inhibited. 2. **Impact of Tregs on AD pathological features**: The study evaluated the inhibitory effect of Tregs on Aβ accumulation and pTAU accumulation. 3. **Impact of Tregs on microglial cell polarization**: The study explored the promoting effect of Tregs on the transformation of microglial cells from pro - inflammatory M1 type to anti - inflammatory M2 type. 4. **Survival time of Tregs in the brain**: The study investigated the survival time of Tregs in the brain and other tissues to understand the mechanism of its long - term efficacy. ### Methods - **Animal model**: Use 4 - month - old 3xTg - AD mice and non - transgenic control mice. - **Treg preparation and transfer**: Amplify Tregs from C57BL/6J mice in vitro and inject them into 3xTg - AD mice via the tail vein. - **Drug treatment**: Use the CSF - 1R inhibitor GW2580 to inhibit microglial cell proliferation. - **Behavior test**: Evaluate the learning and memory abilities of mice through the passive avoidance test (PAT). - **Immunohistochemical analysis**: Detect the accumulation of Aβ and pTAU. - **Flow cytometry**: Detect the survival of Tregs in different tissues. - **Gene expression analysis**: Detect the expression levels of microglial cell - related markers through RT - PCR. ### Results - **GW2580 inhibits microglial cell proliferation**: Short - term use of GW2580 can reduce the number of microglial cells in the brains of 3xTg - AD mice. - **Tregs improve cognitive function**: Even under GW2580 treatment, the transfer of Tregs can still significantly improve the cognitive dysfunction of 3xTg - AD mice. - **Tregs reduce Aβ and pTAU accumulation**: The transfer of Tregs significantly reduces the accumulation of Aβ and pTAU in the brains of 3xTg - AD mice, whether GW2580 is used or not. - **Tregs regulate microglial cell polarization**: The transfer of Tregs significantly reduces the expression of markers of pro - inflammatory M1 - type microglial cells and increases the expression of markers of anti - inflammatory M2 - type microglial cells at the same time. - **Tregs survive in the brain for a long time**: Tregs can survive in the brain for more than 100 days and continuously play their neuroprotective role. ### Conclusion This study shows that even when microglial cell proliferation is inhibited, Tregs can still effectively improve cognitive dysfunction in 3xTg - AD mice, reduce the accumulation of Aβ and pTAU, and regulate the polarization of microglial cells. These findings support the potential application value of Tregs in AD treatment.

Blocking Microglial Proliferation by CSF-1R Inhibitor Does Not Alter the Neuroprotective Effects of Adoptive Regulatory T Cells in 3xTg Alzheimer’s Disease Mice